Skip to main content
Clinical Trials/NCT02980393
NCT02980393
Completed
N/A

The Impact of a Structured Lifestyle Intervention on Body Composition and Exercise Capacity in Overweight Children With Operated Heart Defects

Kambiz Norozi0 sites40 target enrollmentMay 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
Kambiz Norozi
Enrollment
40
Primary Endpoint
Change in Baseline Fat Mass at 1 year
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study is to assess whether a lifestyle intervention with diet, exercise and counselling in young patients will have a positive influence on their weight and overall well-being. This study will enrol patients between the ages of 7 to 17 years of age, who have congenital heart disease, and have been identified being overweight or obese. A total of 40 individuals will participate in this study. The study duration will last for 1 year.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
November 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Kambiz Norozi
Responsible Party
Sponsor Investigator
Principal Investigator

Kambiz Norozi

Paediatric Cardiologist

Western University, Canada

Eligibility Criteria

Inclusion Criteria

  • overweight or obese (BMI\> 85%) patients
  • between 7-17 years of age
  • operated or non-operated congenital heart disease
  • reside in Southwestern Ontario

Exclusion Criteria

  • inability to comply with research testing or intervention components due to mental and/or physical disabilities, medications or comorbidities affecting weight or metabolic condition
  • involvement in any concurrent lifestyle intervention program

Outcomes

Primary Outcomes

Change in Baseline Fat Mass at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure fat mass.

Change in Baseline Visceral Adipose Tissue at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure visceral adipose tissue.

Change in Baseline Lean Mass at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure lean mass.

Change in Baseline Bone Mineral Content at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure bone mineral content.

Change in Baseline Percent Fat at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure percent fat.

Change in Baseline Body Mass Index (BMI) at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

BMI is derived from body mass divided by the square of the body height

Change in Baseline Percent Android Fat at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure percent android fat.

Change in Baseline Maximum Oxygen Consumption at 1 year

Time Frame: This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Maximal exercise graded treadmill test will determine maximal oxygen consumption.

Secondary Outcomes

  • Change in Baseline Adiponectin at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Physical Activity Levels at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Self-Report Physical Activity Levels at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Muscle function at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Transthoracic echocardiographic measurement at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Endothelial vasodilator function at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Creatinine at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Electrocardiographic measurement at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Urea at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Average Caloric Intake at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Electrolytes at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Fasting Glucose at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Serum Insulin at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Quality of Life at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)
  • Change in Baseline Lipid Profile at 1 year(This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame)

Similar Trials